CALA - Calithera Biosciences reports Q2 results August, 15 2022 04:15 PM Calithera Biosciences Inc. Calithera Biosciences press release ( NASDAQ: CALA ): Q2 Net loss was $9.1 million for the three months ended June 30, 2022. Cash and cash equivalents totaled $41.8 million at June 30, 2022. For further details see: Calithera Biosciences reports Q2 results